O14733 (MP2K7_HUMAN) Homo sapiens (Human)

Dual specificity mitogen-activated protein kinase kinase 7 UniProtKBInterProSTRINGInteractive Modelling

419 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4); 6 identical sequences: Pongo abelii: A0A2J8RD71; Pan troglodytes: K7CKG2, A0A803KLG6; Gorilla gorilla gorilla: G3R9J9; Macaca mulatta: H9EQH1; Piliocolobus tephrosceles: A0A8C9I693

Available Structures

36 Experimental Structures

DescriptionPDB IDOligo-stateRangeLigands
Crystal structure of JNK1 bound to a MKK7 docking motif Heteromer
P45983;
39-48
ANP;SO4;
Assess
Crystal structure of MKK7 (MAP2K7) in an active state, allosterically triggered by the N-terminal h…monomer86-404
NA; 17×EDO;
Assess
MAP2K7 mutant -C218Smonomer103-419
GOL;
Assess
MAP2K7 C218S mutant-inhibitormonomer103-419
95U;
Assess
Crystal structure of MKK7 (MAP2K7), apo formmonomer100-405
Assess
Crystal structure of MKK7 (MAP2K7) with ibrutinib bound at allosteric sitemonomer101-404
EDO;DMS;1E8;
Assess
Crystal structure of MKK7 (MAP2K7) in complex with ibrutnib, with covalent and allosteric binding m…monomer102-404
EDO;DMS;1E8;8E8;
Assess
Crystal structure of MKK7 (MAP2K7) in complex with ASC69monomer101-403
IHH;
Assess
Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor SB1-G-23monomer102-403
EDO;OQ2;
Assess
Protein kinase MKK7 in complex with difluoro-phenethyltriazole-substituted pyrazolopyrimidinemonomer102-403
24N;
Assess
Protein kinase MKK7 in complex with phenethyltriazole-substituted pyrazolopyrimidinemonomer102-402
2GI;
Assess
Crystal structure of S287D,T291D MKK7 (MAP2K7), apo formmonomer102-402
Assess
Crystal structure of MKK7 (MAP2K7) covalently bound with type-II inhibitor TL10-105monomer103-403
EDO;OQ8;
Assess
Structure of the mitogen activated kinase kinase 7 active conformationmonomer102-402
Assess
MAP2K7 C276S mutant-inhibitormonomer103-403
95U;EPE;
Assess
Structure of the mitogen activated kinase kinase 7 dfg-out conformationmonomer102-402
Assess
Protein kinase MKK7 in complex with methoxycyclohexyl-substituted indazolemonomer102-402
1XZ;
Assess
Protein kinase MKK7 in complex with tolyl-substituted indazolemonomer102-402
2I8;
Assess
Protein kinase MKK7 in complex with cyclobutyl-substituted indazolemonomer102-402
21I;
Assess
Protein kinase MKK7 in complex with 5-bromo-2-hydroxyphenyl-substituted pyrazolopyrimidinemonomer102-401
GOL;2I5;
Assess
Crystal structure of MAP2K7 complexed with a covalent inhibitor 12monomer103-402
FU6;GOL;
Assess
The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 4amonomer102-401
862;
Assess
Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1kmonomer102-401
6HL;
Assess
A crucial role of Cys218 in the stabilization of an unprecedented auto-inhibition form of MAP2K7monomer104-403
EPE;GOL;
Assess
Crystal structure of human mitogen-activated protein kinase kinase 7 activated mutant (S287D, T291D)monomer103-402
Assess
The structure of MKK7 in complex with the covalent 4-amino-pyrazolopyrimidine 3amonomer101-400
H8Z;PG4;
Assess
Crystal structure of the C276S mutant of MAP2K7monomer103-402
Assess
Crystal structure of MKK7 (MAP2K7) in complex with K00007monomer103-401
EDO;SU9;
Assess
Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidin 1bmonomer102-400
J0B;
Assess
THE STRUCTURE OF MAP2K7 IN COMPLEX WITH 5Z-7-oxozeaenolmonomer104-402
1FM;
Assess
Crystal structure of MKK7 (MAP2K7) covalently bound with CPT1-70-1monomer103-400
EDO;6HF;
Assess
A crucial role of Cys218 in the stabilization of an unprecedented auto-inhibition form of MAP2K7monomer104-400
Assess
A crucial role of Cys218 in the stabilization of an unprecedented auto-inhibition form of MAP2K7monomer105-400
Assess
Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine inhibitor 1hmonomer111-401
J0E;
Assess
Structure of the mitogen activated kinase kinase 7 in complex with pyrazolopyrimidine 1mmonomer111-401
J3N;
Assess
Dual specificity mitogen-activated protein kinase kinase 7 in complex with pyrazolopyrimidine 1amonomer111-401
J3H;
Assess

1 SWISS-MODEL model

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
6yg1.1.Amonomer0.8486-404
99.42
Assess

4 SWISS-MODEL models built on isoform sequence

TemplateIsoformOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 26yg1.1.Amonomer0.7886-447
99.13
Assess
Isoform 26em7.1.Amonomer0.62130-427
22.95
Assess
Isoform 36yg1.1.Amonomer0.84102-420
99.42
Assess
Isoform 46yg1.1.Amonomer0.8286-411
99.42
Assess